Fenofibrate pre-treatment suppressed inflammation by activating phosphoinositide 3 kinase/protein kinase B (PI3K/Akt) signaling in renal ischemia-reperfusion injury

Abstract

The aim of this study was to investigate the possible beneficial effects of Fenofibrate on renal ischemia-reperfusion injury (IRI) in mice and its potential mechanism. IRI was induced by bilateral renal ischemia for 60 min followed by reperfusion for 24 h. Eighteen male C57BL/6 mice were randomly divided into three groups: sham-operated group (sham), IRI+saline group (IRI group), IRI+Fenofibrate (FEN) group. Normal saline or Fenofibrate (3 mg/kg) was intravenously injected 60 min before renal ischemia in IRI group and FEN group, respectively. Blood samples and renal tissues were collected at the end of reperfusion. The renal function, histopathologic changes, and the expression levels of pro-inflammatory cytokines [interleukin-8 (IL-8), tumor necrosis factor alpha (TNF-α) and IL-6] in serum and renal tissue homogenate were assessed. Moreover, the effects of Fenofibrate on activating phosphoinositide 3 kinase/protein kinase B (PI3K/Akt) signaling and peroxisome proliferator-activated receptor-α (PPAR-α) were also measured in renal IRI. The results showed that plasma levels of blood urea nitrogen and creatinine, histopathologic scores and the expression levels of TNF-α, IL-8 and IL-6 were significantly lower in FEN group than in IRI group. Moreover, Fenofibrate pretreatment could further induce PI3K/Akt signal pathway and PPAR-α activation following renal IRI. These findings indicated PPAR-α activation by Fenofibrate exerts protective effects on renal IRI in mice by suppressing inflammation via PI3K/Akt activation. Thus, Fenofibrate could be a novel therapeutic alternative in renal IRI.

Keywords

Fenofibrate / renal ischemia/reperfusion injury / activating phosphoinositide 3 kinase/protein kinase B / inflammation

References

[1] ManganoCM, DiamondstoneLS, RamsayJG, et al. . Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med, 1998, 128(3): 194-203 PMID: 9454527

[2] AydinZ, van ZonneveldAJ, de FijterJW, et al. . New horizons in prevention and treatment of ischaemic injury to kidney transplants. Nephrol Dial Transplant, 2007, 22(2): 342-346 PMID: 17132706

[3] ChertowGM, BurdickE, HonourM, et al. . Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol, 2005, 16(11): 3365-3370 PMID: 16177006

[4] KazmersA, JacobsL, PerkinsA. The impact of complications after vascular surgery in Veterans Affairs Medical Centers. J Surg Res, 1997, 67(1): 62-66 PMID: 9070183

[5] LevyEM, ViscoliCM, HorwitzRI. The effect of acute renal failure on mortality. A cohort analysis. JAMA, 1996, 275(19): 1489-1494 PMID: 8622223

[6] ZhangJ, LiJH, WangL, et al. . Glucocorticoid receptor agonist dexamethasone attenuates renal ischemia/reperfusion injury by up-regulating eNOS/iNOS. J Huazhong Univ Sci Technolog Med Sci, 2014, 34(4): 516-520 PMID: 25135720

[7] SchifflH, LangSM, FischerR. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med, 2002, 346(5): 305-310 PMID: 11821506

[8] AmuraCR, RennerB, LyubchenkoT, et al. . Complement activation and toll-like receptor-2 signaling contribute to cytokine production after renal ischemia/reperfusion. Mol Immunol, 2012, 52(3–4): 249-257 PMCID: 3405836 PMID: 22750071

[9] FanLH, HeL, CaoZQ, et al. . Effect of ischemia preconditioning on renal ischemia/reperfusion injury in rats. Int Braz J Urol, 2012, 38(6): 842-854 PMID: 23302405

[10] KuschA, HoffU, BubaloG, et al. . Novel signalling mechanisms and targets in renal ischaemia and reperfusion injury. Acta Physiol (Oxf), 2013, 208(1): 25-40

[11] KimHJ, JoeY, KongJS, et al. . Carbon monoxide protects against hepatic ischemia/reperfusion injury via ROS-dependent Akt signaling and inhibition of glycogen synthase kinase 3beta. Oxid Med Cell Longev, 2013, 2013: 306421 PMCID: 3880761 PMID: 24454979

[12] HofmannBT, JuckerM. Activation of PI3K/Akt signaling by n-terminal SH2 domain mutants of the p85alpha regulatory subunit of PI3K is enhanced by deletion of its c-terminal SH2 domain. Cell Signal, 2012, 24(10): 1950-1954 PMID: 22735814

[13] ChenL, WeiX, HouY, et al. . Tetramethylpyrazine analogue CXC195 protects against cerebral ischemia/reperfusion-induced apoptosis through PI3K/Akt/GSK3beta pathway in rats. Neurochem Int, 2014, 66: 27-32 PMID: 24462584

[14] RasinMS. Peroxisome proliferator-activated receptors-gamma and hypertension: lessons of the history of researches. Ter Arkh, 2013, 85(9): 118-123 PMID: 24261241

[15] Guebre-EgziabherF, AlixPM, KoppeL, et al. . Ectopic lipid accumulation: A potential cause for metabolic disturbances and a contributor to the alteration of kidney function. Biochimie, 2013, 95(11): 1971-1979 PMID: 23896376

[16] BulhakAA, JungC, OstensonCG, et al. . PPAR-alpha activation protects the type 2 diabetic myocardium against ischemia-reperfusion injury: involvement of the PI3-Kinase/Akt and NO pathway. Am J Physiol Heart Circ Physiol, 2009, 296(3): H719-727 PMID: 19151258

[17] PatelNS, di PaolaR, MazzonE, et al. . Peroxisome proliferator-activated receptor-alpha contributes to the resolution of inflammation after renal ischemia/reperfusion injury. J Pharmacol Exp Ther, 2009, 328(2): 635-643 PMID: 18997058

[18] DongC, HuY, WangH, et al. . Inhibitory effects of fenofibrate on plasminogen activator inhibitor-1 expression in human endothelial cells. Huazhong Univ Sci Technolog Med Sci, 2006, 26(2): 192-193

[19] J Mol Histol, 2013, 44(4

[20] YangC, ZhaoT, LinM, et al. . Helix B surface peptide administered after insult of ischemia reperfusion improved renal function, structure and apoptosis through beta common receptor/erythropoietin receptor and PI3K/Akt pathway in a murine model. Exp Biol Med (Maywood), 2013, 2381): 111-119

[21] XieL, ZhengX, QinJ, et al. . Role of PI3-kinase/Akt signalling pathway in renal function and cell proliferation after renal ischaemia/reperfusion injury in mice. Nephrology (Carlton), 2006, 11(3): 207-212

[22] LiuWH, LiuHB, GaoDK, et al. . ABCG2 protects kidney side population cells from hypoxia/reoxygenation injury through activation of the MEK/ERK pathway. Cell Transplant, 2013, 22(10): 1859-1868 PMID: 23032069